FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...

European countries must match ambition with action — and reward the kind of pharmaceutical innovation they say they want to lead.

Today, the National Institute for Health and Care Excellence (NICE) published its preliminary optimised recommendation 1 for ribociclib to be used as adjuvant treatment in combination with an ...

Explore opportunities with Novartis below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Novartis is reimagining medicine to improve and extend people’s lives. We provide financial support for educational, advocacy and outreach activities that help advance our goals of improving patient ...

People living with Sjögren’s face a physical, mental, and economic burden that often goes unseen and can interfere with daily life. 7,8 Sjögren's can be challenging to recognize and diagnose because ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

ノバルティス は 障害 を 持 つ 個人 と 協力 し、 合理的配慮 を 提供 することをお 約束 します。健康状態 や 障害 を 理由 に 採用 プロセス のいかなる 部分 においても、あるいは 職務 の ...

Novartis is committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for ...

Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...

诺华 承 诺 与残障人士共事并 为 他 们 提供合理的便利 设 施。如果您由于健康状况或残障 在招聘 过 程的任何 环 节 需要合理便利 设 施 或者 为 了履行 职 位的基本 职 能 请发 送 电 子 邮 件 ...